Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Congress Scientific Watch

The Congress Scientific Watch provides ESMO Members with fresh comments and analysis from selected abstracts presented during major international Oncology meetings.

Login to start reading, or Join ESMO - All articles are Open Access after 6 months.

Filter by:

58 results

Targeted Therapy;  Molecular Oncology;  Central Nervous System Malignancies

INDIGO Supports Vorasidenib For IDH-Mutant Grade 2 Diffuse Glioma

From ASCO 2023 Annual Meeting:
Vorasidenib extends progression-free survival and delays the requirement for further intervention in patients with IDH-mutant WHO grade 2 diffuse glioma

Cytotoxic Therapy;  Immunotherapy;  Cervical Cancer

Final KEYNOTE-826 Survival Findings Support Pembrolizumab Use

From ASCO 2023 Annual Meeting:
Survival outcomes for persistent, recurrent or metastatic cervical cancer are significantly improved with the use of pembrolizumab alongside chemotherapy, regardless of bevacizumab therapy

Cytotoxic Therapy;  Immunotherapy;  Surgical Oncology;  Non-Small Cell Lung Cancer

Perioperative Pembrolizumab Strategy Improves Resectable NSCLC Outcomes

From ASCO 2023 Annual Meeting:
Interim KEYNOTE-671 findings demonstrate an event-free survival benefit with use of pembrolizumab before and after surgery for patients undergoing treatment for early-stage, non-small-cell lung cancer  

Targeted Therapy;  Clinical Research;  Breast Cancer;  Head and Neck Cancers

Mutant-Specific PI3Kα Inhibitor Overcomes Toxicity Limitations of Drug Class

From the 2023 AACR Annual Meeting:
RLY-2608, a mutant-selective PI3Kα inhibitor, may offer patients with PIK3CA-mutant solid tumours a chance of treatment without experiencing the toxic effects of non-selective PI3Kα inhibition  

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.